U.S. Tobacco Stock News

NYSEAM:IE
NYSEAM:IEMetals and Mining

Is Ivanhoe Electric's (IE) New Santa Cruz Operations Team a Turning Point for Execution Risk?

Ivanhoe Electric has announced the appointment of mining veterans Michelle Lammers as Chief Operating Officer and Daniel Worthy as Senior Vice President, Operations and General Manager for the Santa Cruz Copper Project in Arizona, with both roles effective from September 1, 2026. The move signals a clear push to strengthen operational leadership around the Santa Cruz Copper Project by bringing in executives with deep experience running large, complex North American mining operations. Next,...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

Is NBT Bancorp (NBTB) A Bargain As Higher Earnings And Dividend Growth Lift Interest?

Why NBT Bancorp Stock Is In Focus After Its Latest Quarter NBT Bancorp (NBTB) has drawn fresh attention after reporting higher net interest income and net income for the second quarter of 2026, alongside a larger cash dividend and continued share buybacks. See our latest analysis for NBT Bancorp. The latest earnings, higher dividend and ongoing buybacks come against a strong backdrop for NBT Bancorp, with the share price at $52.91 and a year to date share price return of 27.22%, while the 1...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Stock Sinks As Losses Deepen Despite Higher Guidance

Mirum Pharmaceuticals came into this earnings season with a bruised stock, down over 26% in the past month, and the selloff accelerated today with an 11% slide to about US$94. Yet the headline from Q2 is not collapse but commercial heft. Net product sales reached US$176.2m and management lifted full year 2026 sales guidance to a range of US$680m to US$700m. The catch sits on the income statement. Mirum reported a quarterly net loss of US$67.2m and basic earnings per share of US$1.06 in the...
NYSE:OKE
NYSE:OKEOil and Gas

How Investors May Respond To ONEOK (OKE) Raising 2026 Guidance and Launching US$1 Billion Stock Offering

In early August 2026, ONEOK, Inc. reported second-quarter 2026 results showing higher revenue of US$12.05 billion and net income of US$966 million year on year, raised its 2026 net income and EPS guidance, and filed for a US$1.00 billion at-the-market follow-on common stock offering. The guidance increase, supported by higher natural gas liquids and refined-products volumes plus tax benefits and new infrastructure capacity, highlights how ONEOK is leaning on project execution and balance...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Raises Fresh Capital After Wider Losses, Is It Still Undervalued?

Viking Therapeutics (VKTX) is back in focus after reporting wider second quarter losses alongside a series of at the market equity offerings and a new universal shelf registration that increase its funding flexibility. See our latest analysis for Viking Therapeutics. Viking Therapeutics' share price has eased in the short term, with a 30 day share price return down 21%, while the 3 year total shareholder return of about 124% and 5 year total shareholder return above 7x show a very strong...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 (PSX) Posted Strong Q2 Earnings, Does It Look Fully Valued?

Phillips 66 (PSX) is back in focus after reporting second quarter 2026 earnings on 5 August, with revenue of US$52.0b and net income of US$3.8b from continuing operations. See our latest analysis for Phillips 66. The strong Q2 2026 report, a US$10b increase in the share repurchase authorization announced on 31 July, and new gas and NGL projects in Texas have coincided with a 57.40% year to date share price return and a 233.47% five year total shareholder return. This suggests momentum has...
NYSE:CNP
NYSE:CNPIntegrated Utilities

CenterPoint Energy (CNP) Stock Looks Pricey After A 72% Five Year Return

CenterPoint Energy stock has delivered a strong 72.5% total return over the past five years. However, the low value score and an intrinsic value estimate that points to a premium price suggest the shares may no longer be an obvious bargain at around US$40.67. Over five years, CenterPoint Energy has returned 72.5%. This puts more pressure on today’s buyers to be confident about what they are paying for. Expected load growth in Texas, including large power demands from data centers, can...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

What Could New Jersey’s Antitrust Lawsuit Mean For Amazon.com (AMZN)?

Amazon.com (NasdaqGS:AMZN) is facing a major antitrust lawsuit from the New Jersey Attorney General that targets its delivery contractor model and alleged suppression of driver wages. The complaint focuses on Amazon's nationwide labor practices in its delivery network and claims the company restricts competition for drivers' services. The case adds fresh legal scrutiny to Amazon's role in the US delivery sector and raises questions about potential changes to its contractor based logistics...
NYSE:LYV
NYSE:LYVEntertainment

The Bull Case For Live Nation Entertainment (LYV) Could Change Following A Profit-Rebound Second Quarter Performance

Live Nation Entertainment, Inc. reported its second-quarter 2026 results, with sales rising to US$7,666.86 million and net income to US$294.45 million, compared with US$7,006.64 million and US$243.41 million a year earlier. Despite a net loss of US$94.66 million for the first half of 2026, the sharp improvement in quarterly earnings per share from US$0.41 to US$1.05 highlights how current operating performance contrasts with weaker earlier periods. We’ll now examine how this stronger...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Holdings (ZBH) Raised Guidance On A Q2 Beat, Does It Look Fairly Valued?

Zimmer Biomet Holdings (ZBH) just reported a second-quarter update that caught investor attention. Revenue and earnings topped analyst expectations, full-year guidance was raised, and the Paragon 28 acquisition and US commercial changes featured prominently. See our latest analysis for Zimmer Biomet Holdings. Zimmer Biomet Holdings' recent Q2 beat and higher guidance have come alongside a clear shift in market sentiment, with the share price at $97.19 and a 90 day share price return of...
NYSE:SRI
NYSE:SRIAuto Components

Stoneridge (SRI) MirrorEye Growth Contrasts With Persistent Margin Pressure

Stoneridge came into this earnings print as a deeply loss making auto supplier that the market has largely priced for trouble. The stock slipped about 3% to US$7.25 after the release. That move understates how much the quarter reshaped the story. Revenue reached US$181.4m with organic growth comfortably ahead of key original equipment manufacturer end markets, and MirrorEye camera systems delivered a record US$37m in sales. The catch is margin quality. Gross margin compressed while adjusted...
NYSE:RVTY
NYSE:RVTYLife Sciences

Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative

In the past week, Revvity, Inc. reported second-quarter 2026 results with sales of US$729.69 million, net income of US$51.82 million, modestly higher diluted EPS, reaffirmed a regular US$0.07 quarterly dividend, and issued full-year 2026 pro forma revenue guidance of US$2.83 billion to US$2.86 billion. Management linked these updates to improving pharma and biotech demand, strong Diagnostics performance, and ongoing progress exiting its China immunodiagnostics business to focus on...
NYSE:TWLO
NYSE:TWLOIT

Twilio’s Q2 Earnings Beat And Buyback Might Change The Case For Investing In TWLO

Twilio Inc. reported past second-quarter 2026 results with sales of US$1,499.09 million and net income of US$1,067.21 million, delivering very large year-on-year earnings growth. The company also completed a US$1.20 billion share repurchase program while boosting profitability metrics such as earnings per share, underscoring improving capital efficiency. Now we’ll consider how Twilio’s strong Q2 earnings beat and upgraded full-year guidance could affect its existing AI-driven growth...
NYSE:MPC
NYSE:MPCOil and Gas

What Marathon Petroleum (MPC)'s Margin‑Fueled Q2 Profit Surge and Payouts Mean For Shareholders

In the past quarter, Marathon Petroleum Corporation reported second‑quarter 2026 revenue of US$52.34 billion and net income of US$5.14 billion, with diluted EPS from continuing operations rising to US$17.73 from US$3.96 a year earlier. This surge in profitability was driven largely by very strong refining margins, high utilization and a refining margin capture of 112%, alongside US$2.5 billion of share buybacks and a US$1.00 per‑share dividend declaration. With these powerful refining...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly (FSLY) Stock Falls As Profit Spike Meets Durability Doubts

Fastly entered this earnings day on a strong short run, with the stock up over the past week and month, then hit a wall. The share price fell about 13% to US$22.68 as investors reacted fast to the headline numbers. The shock is that this edge cloud stock just printed what looks like a clean profitability step change. Revenue for Q2 came in at US$183.3m and Fastly delivered a net income of US$26.2m alongside record gross and operating margins. The market is treating that as a blip. The results...
NYSE:DVA
NYSE:DVAHealthcare

Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story?

In the past quarter, DaVita Inc. reported Q2 2026 revenue of US$3,554.08 million and net income of US$265.4 million, with diluted EPS from continuing operations rising to US$4.02 from US$2.58 a year earlier. Beyond the headline growth, DaVita paired higher earnings with improved patient mortality, stronger treatment volumes, and an accelerated rollout of advanced hemodialysis dialyzers following recent FDA approvals. We'll now examine how DaVita's improved mortality trends and expanding...
NYSE:UNH
NYSE:UNHHealthcare

How Tennessee Health Hubs and Rural Workforce Plans Could Shape UnitedHealth Group’s (UNH) Value-Based Care Story

In July 2026, UnitedHealth Group announced US$4.00 million in new support, alongside technical assistance, to help the University of Tennessee Health Sciences expand its community health hub model statewide from five to 13 locations by the end of 2027, broadening access to preventive and chronic care services for Tennesseans. This expansion, building on nearly US$2.00 million in prior funding and more than 20,000 health hub visits since 2022, highlights UnitedHealth Group’s emphasis on...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

How Q2 Earnings Beat And CNBC Spotlight At J.B. Hunt (JBHT) Has Changed Its Investment Story

In the past few days, J.B. Hunt Transport Services reported second-quarter results that exceeded analyst expectations on both revenue and earnings, and the stock was highlighted as a pick by Virtus Investment Partners’ Joseph M. Terranova on CNBC’s “Final Trades.” This combination of outperforming quarterly results and high-profile media endorsement has drawn fresh attention to how J.B. Hunt’s operations and outlook are being assessed by the market. Next, we’ll examine how J.B. Hunt’s...
NYSE:AIG
NYSE:AIGInsurance

Did AIG's Q2 2026 Profit Dip and Underwriting Shift Just Reshape Its Investment Narrative?

American International Group, Inc. has now reported its second-quarter 2026 results, with net income of US$948 million compared to US$1,144 million a year earlier, and six‑month net income of US$1.71 billion versus US$1.84 billion in the prior-year period. While headline profit eased, the latest update underscored a shift toward healthier underwriting and premium growth, even as weaker net investment income raised questions about the durability of AIG’s earnings mix. We’ll now examine how...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

How Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss

Cytokinetics, Incorporated recently reported second-quarter 2026 results showing revenue of US$28.62 million versus US$66.77 million a year earlier, alongside a wider net loss of US$198.76 million and basic loss per share of US$1.50 from continuing operations. Around the same period, the company’s cardiac myosin inhibitor MYQORZO (aficamten) secured UK marketing authorisation with NICE backing for symptomatic obstructive hypertrophic cardiomyopathy, underscoring early commercial and...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Is LPL Financial (LPLA) Quietly Recasting Its Wealth Platform With New Models And Advisor Inflows?

In recent weeks, LPL Financial expanded its model portfolio platform with 17 new Building Block Model Portfolios, reported higher quarterly revenue and net income year over year, continued share repurchases and dividends, and attracted advisory teams representing hundreds of millions of US$ in client assets from larger rivals. Together, these moves highlight LPL Financial’s effort to deepen its model portfolio capabilities while using capital returns and advisor recruitment to strengthen its...
NYSE:TKO
NYSE:TKOEntertainment

TKO Group Holdings (TKO) Following Earnings And Guidance Lift Still Looks Undervalued

How TKO Group Holdings earnings, guidance and buybacks set the stage for investors TKO Group Holdings (TKO) reported second quarter 2026 results on 3 August, alongside raised full year revenue guidance and an update on its ongoing share repurchase program. Sales for the quarter were US$1,547.08 million compared with US$1,308.44 million a year earlier. Net income was US$101.58 million compared with US$98.37 million, with diluted earnings per share from continuing operations at US$1.34 versus...
NYSE:ELF
NYSE:ELFPersonal Products

e.l.f. Beauty (ELF) Stock Faces Rich Valuation After Guidance Lift

e.l.f. Beauty stock jumped 6.9% to US$92.31 into the close, which indicates traders responded positively to the headline results. The hook is simple: Q1 FY2027 landed with adjusted earnings per share of US$1.75 and adjusted EBITDA of US$168m, both strong numbers for a mass beauty player, and management lifted full-year sales and profit guidance. The short-term reaction reflects that beat and raise. The longer-term question for you is whether those higher multi-year earnings targets justify a...
NasdaqGM:WW
NasdaqGM:WWConsumer Services

WW (WW) Stock Rallies On Margin Strength As Revenue Shrinks

The market is treating WW International like a comeback story, with the stock jumping 9.5% to US$16.88 the day after earnings, yet the numbers still tell a more complicated tale. The headline is margin resilience in a shrinking top line. Q2 revenue came in at US$162.3m while gross margin held at 70.3% and adjusted gross margin sat even higher at 73.6%. For a subscription based weight management business that lives and dies on churn and pricing power, that kind of margin stability is what has...